FDA Approves Durvalumab for Limited-Stage Small Cell Lung Cancer By Ogkologos - January 17, 2025 605 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the ADRIATIC study Source RELATED ARTICLESMORE FROM AUTHOR Patient Guide in Testicular Cancer Now Available Also in Italian Adding 177Lu-PNT2002 to SBRT Significantly Improves PFS in Patients with Oligorecurrent Hormone-Sensitive Prostate Cancer A Short-Course Dose Escalation Strategy Could Improve Ability to Reach Target Dose of Adjuvant Abemaciclib in High-Risk Early-Stage HR-positive, HER2-negative Breast Cancer MOST POPULAR Mom Walks In To Comfort Scared Son After Surgery And Sees... June 26, 2019 Strategy May Prevent Tumor Resistance to Targeted Cancer Therapies March 17, 2023 AI and remote monitoring are shaping a new patient journey in... August 26, 2025 Alex Trebek Has Completed Chemo And Will Be Back For The... September 11, 2019 Load more HOT NEWS Use of Immune Checkpoint Inhibitors is Safe and Effective in Patients... After Being Told a Lump Was Benign, Teenager Learns She Has... ‘Inside Edition’ Anchor Thanks Viewer For Pointing Out Lump That Turned... Lion With Skin Cancer Has Received Radiation Therapy In Hospital
